IC
SONN

Intersect Capital’s Sonnet BioTherapeutics SONN Stock Holding History

Intersect Capital’s Portfolio SONN Stock Details SONN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Hold
0
– -$21K – 176
2019
Q1 		– Hold
0
– – – 142
2018
Q4 		– Hold
0
– – – 128
2018
Q3 		– Hold
0
– – – 128
2018
Q2 		– Hold
0
– – – 126
2018
Q1 		– Hold
0
– – – 118
2017
Q4 		– Hold
0
– – – 115
2017
Q3 		– Hold
0
– – – 110
2017
Q2 		– Hold
0
– – – 108
2017
Q1 		– Hold
0
– – – 87
2016
Q4 		– Hold
0
– – – 94
2016
Q3 		– Hold
0
– – – 91
2016
Q2 		– Hold
0
– – – 107
2016
Q1 		– Hold
0
– – – 105
2015
Q4 		– Hold
0
– – – 91
2015
Q3 		– Hold
0
– – – 90

Other funds holding SONN

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
QCIG
Quad-Cities Investment Group Davenport, Iowa $278M AUM 22.38% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return